Different measures of sodium intake and the risk of metabolic dysfunction-associated steatotic liver disease: Evidence from the UK Biobank Shiqi Zhu; Lihe Liu; Yiping Shen; Rui Li; Jiaxi Lin; Lu Liu; Xiaolin Liu; Hongpeng Sun; Jinzhou Zhu;

FLI and FIB-4 in diagnosing metabolic dysfunction-associated steatotic liver disease in primary care: High prevalence and risk of significant disease Mário Reis Álvares-da-Silva; Márcia da Silva Vargas; Soheyla Mohd Souza Rabie; Gabriella Jonko; Patricia Gabriela Riedel; Larisse Longo; Marcelo Rodrigues Gonçalves; Vivian Cristine Luft; Dvora Joveleviths;

Accurate prediction of all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease using electronic health records Ignat Drozdov; Benjamin Szubert; Ian A. Rowe; Timothy J. Kendall; Jonathan A. Fallowfield;